The role of sex steroids and gonadectomy in the control of thymic involution

Cellular Immunology

Volumn 252, Issue 1-2, 2008, Pages 122-138

  Hince, Melanie ^a   Sakkal, Samy ^a   Vlahos, Katerina ^a   Dudakov, Jarrod ^a   Boyd, Richard ^a   Chidgey, Ann ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Aging; Gonadectomy; LHRH; Sex steroids; Thymic involution; Thymus

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; ANTIANDROGEN; ANTIESTROGEN; ANTIGEN; CORTICOTROPIN RELEASING FACTOR; CYTOKINE; ESTROGEN; ESTROGEN RECEPTOR; FLUTAMIDE; FOLLITROPIN; GONADORELIN; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; GONADORELIN DERIVATIVE; GROWTH FACTOR; HUMAN GROWTH HORMONE; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 14; INTERLEUKIN 2; INTERLEUKIN 7; INTERLEUKIN 9; PROGESTERONE; SEX HORMONE; TAMOXIFEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADAPTIVE IMMUNITY; AGING; AUTOIMMUNE DISEASE; BONE MARROW; CANCER RELAPSE; CASTRATION; CHEMOTHERAPY; ENGRAFTMENT; GENITAL SYSTEM; GONADECTOMY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HORMONE SYNTHESIS; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; IMMUNE DEFICIENCY; IMMUNE SYSTEM; IMMUNITY; INFECTION RISK; LYMPHOPOIESIS; MEMORY CELL; NONHUMAN; OVARIECTOMY; PREGNANCY; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; SEX DIFFERENCE; T LYMPHOCYTE; THYMIC AGING; THYMUS; THYMUS ATROPHY;

AGING; ANIMALS; ATROPHY; DISEASE SUSCEPTIBILITY; GONADAL STEROID HORMONES; HUMANS; THYMUS GLAND;

EID: 46149086028     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2007.10.007     Document Type: Review

References (206)

1. Ye P., and Kirschner D.E. Reevaluation of T cell receptor excision circles as a measure of human recent thymic emigrants. J. Immunol. 168 (2002) 4968-4979
2. Luettig B., Sponholz A., Heerwagen C., Bode U., and Westermann J. Recent thymic emigrants (CD4+) continuously migrate through lymphoid organs: within the tissue they alter surface molecule expression. Scand. J. Immunol. 53 (2001) 563-571
3. Sempowski G.D., Gooding M.E., Liao H.X., Le P.T., and Haynes B.F. T cell receptor excision circle assessment of thymopoiesis in aging mice. Mol. Immunol. 38 (2002) 841-848
4. Linton P., Li S.P., Zhang Y., Bautista B., Huynh Q., and Trinh T. Intrinsic versus environmental influences on T-cell responses in aging. Immunol. Rev. 205 (2005) 207-219
5. Steffens C.M., Al-Harthi L., Shott S., Yogev R., and Landay A. Evaluation of thymopoiesis using T cell receptor excision circles (TRECs): differential correlation between adult and pediatric TRECs and naive phenotypes. Clin. Immunol. 97 (2000) 95-101
6. Aspinall R., and Andrew D. Thymic involution in aging. J. Clin. Immunol. 20 (2000) 250-256
7. Aw D., Silva A.B., and Palmer D.B. Immunosenescence: emerging challenges for an ageing population. Immunology 120 (2007) 435-446
8. Henson S.M., King A.A., Costantino R.F., Cushing J.M., Dennis B., and Desharnais R.A. Explaining and predicting patterns in stochastic population systems. Proc. Biol. Sci. 270 (2003) 1549-1553
9. Yoshikawa T.T. Epidemiology and unique aspects of aging and infectious diseases. Clin. Infect. Dis. 30 (2000) 931-933
10. Cavenagh J.D., Milne T.M., Macey M.G., and Newland A.C. Thymic function in adults: evidence derived from immune recovery patterns following myeloablative chemotherapy and stem cell infusion. Br. J. Haematol. 97 (1997) 673-676
11. Steinmann G.G., Klaus B., and Muller-Hermelink H.K. The involution of the ageing human thymic epithelium is independent of puberty. A morphometric study. Scand. J. Immunol. 22 (1985) 563-575
12. Flores K., Li J., Sempowski G., Haynes B., and Hale L. Analysis of the human thymic perivascular space during aging. J. Clin. Invest. 104 (1999) 1031-1039
13. Nabarra B., and Andrianarison I. Ultrastructural study of thymic microenvironment involution in aging mice. Exp. Gerontol. 31 (1996) 489-506
14. Fabris N., Moccheigiani E., and Provinciali M. Plasticity of neuroendocrine-thymus interactions during aging. Exp. Gerontol. 32 (1997) 415-429
15. Murata S., Sasaki K., Kishimoto T., Niwa S., Hayashi H., Takahama Y., and Tanaka K. Regulation of CD8+ T cell development by thymus-specific proteasomes. Science 316 (2007) 1349-1353
16. Takahama Y. Journey through the thymus: stromal guides for T-cell development and selection. Nat. Rev. Immunol. 6 (2006) 127-135
17. Gray D.H., Tull D., Ueno T., Seach N., Classon B.J., Chidgey A., McConville M.J., and Boyd R.L. A unique thymic fibroblast population revealed by the monoclonal antibody MTS-15. J. Immunol. 178 (2007) 4956-4965
18. Mackall C.L., Punt J.A., Morgan P., Farr A.G., and Gress R.E. Thymic function in young/old chimeras: substantial thymic T cell regenerative capacity despite irreversible age-associated thymic involution. Eur. J. Immunol. 28 (1998) 1886-1893
19. Scollay R., Smith J., and Stauffer V. Dynamics of early T cells: prothymocyte migration and proliferation in the adult mouse thymus. Immunol. Rev. 91 (1986) 129-157
20. Brelinska R. Thymic epithelial cells in age-dependent involution. Microsc. Res. Tech. 62 (2003) 488-500
21. Min H., Montecino-Rodriguez E., and Dorshkind K. Reduction in the developmental potential of intrathymic T Cell progenitors with age. J. Immunol. 173 (2004) 245-250
22. Heng T.S., Goldberg G., Sutherland J., Gray D., and Boyd R. Effects of castration on thymocyte development in two different models of thymic involution. J. Immunol. 175 (2005) 2982-2993
23. Akbar A.N., and Fletcher J.M. Memory T cell homeostasis and senescence during aging. Curr. Opin. Immunol. 17 (2005) 480-485
24. Linton P., and Dorshkind K. Age-related changes in lymphocyte development and function. Nat. Immunol. 5 (2004) 133-139
25. Aspinall R. Age-associated thymic atrophy in the mouse is due to a deficiency affecting rearrangement of the TCR during intrathymic T cell development. J. Immunol. 158 (1997) 3037-3045
26. Utsuyama M., Hirokawa K., Kurashima C., Fukayama M., Inamatsu T., Suzuki K., Hashimoto W., and Sato K. Differential age-change in the numbers of CD4+CD45RA+ and CD4+CD29+ T cell subsets in human peripheral blood. Mech. Ageing Dev. 63 (1992) 57-68
27. van den Dool C., and de Boer R.J. The effects of age, thymectomy, and HIV Infection on alpha and beta TCR excision circles in naive T cells. J. Immunol. 177 (2006) 4391-4401
28. Douek D.C., McFarland R.D., Keiser P.H., Gage E.A., Massey J.M., Haynes B.F., Polis M.A., Haase A.T., Feinberg M.B., Sullivan J.L., Jamieson B.D., Zack J.A., Picker L.J., and Koup R.A. Changes in thymic function with age and during the treatment of HIV infection. Nature 396 (1998) 690-695
29. Naylor K., Li G., Vallejo A.N., Lee W.W., Koetz K., Bryl E., Witkowski J., Fulbright J., Weyand C.M., and Goronzy J.J. The influence of age on T cell generation and TCR diversity. J. Immunol. 174 (2005) 7446-7452
30. Clise-Dwyer K., Huston G.E., Buck A.L., Duso D.K., and Swain S.L. Environmental and intrinsic factors lead to antigen unresponsiveness in CD4(+) recent thymic emigrants from aged mice. J. Immunol. 178 (2007) 1321-1331
31. Liang Y., Van Zant G., and Szilvassy S.J. Effects of aging on the homing and engraftment of murine hematopoietic stem and progenitor cells. Blood 106 (2005) 1479-1487
32. Garcia G.G., and Miller R.A. Single-cell analyses reveal two defects in peptide-specific activation of naive t cells from aged mice. J. Immunol. 166 (2001) 3151-3157
33. Pawelec G. Immunosenescence: impact in the young as well as the old?. Mech. Ageing Dev. 108 (1999) 1-7
34. Hirokawa K., Utsuyama M., Kasai M., Kurashima C., Ishijima S., and Zeng Y.X. Understanding the mechanism of the age-change of thymic function to promote T cell differentiation. Immunol. Lett. 40 (1994) 269-277
35. Henderson J. On the relationship of the thymus to the sexual organs. 1. The influence of castration on the thymus. J. Physiol. 31 (1904) 222-229
36. Marchetti B., Gallo F., Farinella Z., Tirolo C., Testa N., Caniglia S., and Morale M.C. Gender, neuroendocrine-immune interactions and neuron-glial plasticity. Role of luteinizing hormone-releasing hormone (LHRH). Ann. N. Y. Acad. Sci. 917 (2000) 678-709
37. Lucena E., and Cubillos J. Immune abnormalities in endometriosis compromising fertility in IVF-ET patients. J. Reprod. Med. 44 (1999) 458-464
38. Gleicher N., El-Roeiy A., Confino E., and Friberg J. Reproductive failure because of autoantibodies: unexplained infertility and pregnancy wastage. Am. J. Obstet. Gynecol. 160 (1989) 1376-1380 discussion 1380-1385
39. Morale M.C., Gallo F., Tirolo C., Testa N., Caniglia S., Marletta N., Spina-Purrello V., Avola R., Caucci F., Tomasi P., Delitala G., Barden N., and Marchetti B. Neuroendocrine-immune (NEI) circuitry from neuron-glial interactions to function: focus on gender and HPA-HPG interactions on early programming of the NEI system. Immunol. Cell Biol. 79 (2001) 400-417
40. Batticane N., Morale M.C., Gallo F., Farinella Z., and Marchetti B. Luteinizing hormone-releasing hormone signaling at the lymphocyte involves stimulation of interleukin-2 receptor expression. Endocrinology 129 (1991) 277-286
41. Wong K.H., and Simon J.A. In vitro effect of gonadotropin-releasing hormone agonist on natural killer cell cytolysis in women with and without endometriosis. Am. J. Obstet. Gynecol. 190 (2004) 44-49
42. Kyama C.M., Debrock S., Mwenda J.M., and D'Hooghe T.M. Potential involvement of the immune system in the development of endometriosis. Reprod. Biol. Endocrinol. 1 (2003) 123
43. Marchetti B., Guarcello V., Morale M.C., Bartoloni G., Farinella Z., Cordaro S., and Scapagnini U. Luteinizing hormone-releasing hormone-binding sites in the rat thymus: characteristics and biological function. Endocrinology 125 (1989) 1025-1036
44. Standaert F.E., Chew B.P., De Avila D., and Reeves J.J. Presence of luteinizing hormone-releasing hormone binding sites in cultured porcine lymphocytes. Biol. Reprod. 46 (1992) 997-1000
45. Dixit V.D., Yang H., Udhayakumar V., and Sridaran R. Gonadotropin-releasing hormone alters the T helper cytokine balance in the pregnant rat. Biol. Reprod. 68 (2003) 2215-2221
46. Chen H.F., Jeung E.B., Stephenson M., and Leung P.C. Human peripheral blood mononuclear cells express gonadotropin-releasing hormone (GnRH), GnRH receptor, and interleukin-2 receptor gamma-chain messenger ribonucleic acids that are regulated by GnRH in vitro. J. Clin. Endocrinol. Metab. 84 (1999) 743-750
47. Mann D.R., Akinbami M.A., Lunn S.F., Fraser H.M., Gould K.G., and Ansari A.A. Endocrine-immune interaction: alteractions in immune function resulting from neonatal treatment with a GnRH antagonist and seasonality in male primates. Am. J. Reprod. Immunol. 44 (2000) 30-40
48. Mann D.R., Lunn S.F., Akinbami M.A., Samuel K., Waterfall M., and Fraser H.M. Effect of neonatal treatment with a GnRH antagonist on development of the cell-mediated immune response in marmosets. Am. J. Reprod. Immunol. 42 (1999) 175-186
49. Yellayi S., Teuscher C., Woods J.A., Welsh Jr. T.H., Tung K.S., Nakai M., Rosenfeld C.S., Lubahn D.B., and Cooke P.S. Normal development of thymus in male and female mice requires estrogen/estrogen receptor-alpha signaling pathway. Endocrine 12 (2000) 207-213
50. Berruti A., Dogliotti L., Terrone C., Cerutti S., Isaia G., Tarabuzzi R., Reimondo G., Mari M., Ardissone P., De Luca S., Fasolis G., Fontana D., Rossetti S.R., and Angeli A. Changes in bone mineral density, lean body mass and fat content as measured by dual energy X-ray absorptiometry in patients with prostate cancer without apparent bone metastases given androgen deprivation therapy. J. Urol. 167 (2002) 2361-2367 discussion 2367
51. Kung A.W. Androgen and bone mass in men. Asian J. Androl. 5 (2003) 148-154
52. Sutherland J.S., Goldberg G.L., Hammett M.V., Uldrich A.P., Berzins S.P., Heng T.S., Blazar B.R., Millar J.L., Malin M.A., Chidgey A.P., and Boyd R.L. Activation of thymic regeneration in mice and humans following androgen blockade. J. Immunol. 175 (2005) 2741-2753
53. Safadi F.F., Dissanayake I.R., Goodman G.G., Jago R.A., Baker A.E., Bowman A.R., Sass D.A., Popoff S.N., and Epstein S. Influence of estrogen deficiency and replacement on T-cell populations in rat lymphoid tissues and organs. Endocrine 12 (2000) 81-88
54. Fitzpatrick F., Lepault F., Homo-Delarche F., Bach J.F., and Dardenne M. Influence of castration, alone or combined with thymectomy, on the development of diabetes in the nonobese diabetic mouse. Endocrinology 129 (1991) 1382-1390
55. Goldberg G.L., Sutherland J.S., Hammet M.V., Milton M.K., Heng T.S., Chidgey A.P., and Boyd R.L. Sex steroid ablation enhances lymphoid recovery following autologous hematopoietic stem cell transplantation. Transplantation 80 (2005) 1604-1613
56. Goldberg G.L., Alpdogan O., Muriglan S.J., Hammett M.V., Milton M.K., Eng J.M., Hubbard V.M., Kochman A., Willis L.M., Greenberg A.S., Tjoe K.H., Sutherland J.S., Chidgey A., van den Brink M.R., and Boyd R.L. Enhanced immune reconstitution by sex steroid ablation following allogeneic hemopoietic stem cell transplantation. J. Immunol. 178 (2007) 7473-7484
57. Azad N., LaPaglia N., Agrawal L., Steiner J., Uddin S., Williams D.W., Lawrence A.M., and Emanuele N.V. The role of gonadectomy and testosterone replacement on thymic luteinizing hormone-releasing hormone production. J. Endocrinol. 158 (1998) 229-235
58. Li J., and McMurray R.W. Effects of estrogen receptor subtype-selective agonists on immune functions in ovariectomized mice. Int. Immunopharmacol. 6 (2006) 1413-1423
59. Leposavic G., Obradovic S., Kosec D., Pejcic-Karapetrovic B., and Vidic-Dankovic B. In vivo modulation of the distribution of thymocyte subsets by female sex steroid hormones. Int. Immunopharmacol. 1 (2001) 1-12
60. Olsen N.J., Viselli S.M., Fan J., and Kovacs W.J. Androgens accelerate thymocyte apoptosis. Endocrinology 139 (1998) 748-752
61. Aboudkhil S., Bureau J.P., Garrelly L., and Vago P. Effects of castration, depo-testosterone and cyproterone acetate on lymphocyte T subsets in mouse thymus and spleen. Scand. J. Immunol. 34 (1991) 647-653
62. Grossman C.J. Interactions between the gonadal steroids and the immune system. Science 227 (1985) 257-261
63. Olsen N.J., Olsen G., Viselli S.M., Gu X., and Kovacs W.J. Androgen receptors in thymic epithelium modulate thymus size and thymocyte development. Endocrinology 142 (2001) 1278-1283
64. Kumar N., Shan L.X., Hardy M.P., Bardin C.W., and Sundaram K. Mechanism of androgen-induced thymolysis in rats. Endocrinology 136 (1995) 4887-4893
65. Cutolo M., Capellino S., Montagna P., Ghiorzo P., Sulli A., and Villaggio B. Sex hormone modulation of cell growth and apoptosis of the human monocytic/macrophage cell line. Arthritis Res. Ther. 7 (2005) R1124-R1132
66. Guevara Patino J.A., Marino M.W., Ivanov V.N., and Nikolich-Zugich J. Sex steroids induce apoptosis of CD8+CD4+ double-positive thymocytes via TNF-alpha. Eur. J. Immunol. 30 (2000) 2586-2592
67. Ladics G.S., Smith C., Nicastro S.C., Loveless S.E., Cook J.C., and O'Connor J.C. Evaluation of the primary humoral immune response following exposure of male rats to 17beta-estradiol or flutamide for 15 days. Toxicol. Sci. 46 (1998) 75-82
68. Olsen N.J., and Kovacs W.J. Gonadal steroids and immunity. Endocr. Rev. 17 (1996) 369-384
69. Brunelli R., Frasca D., Baschieri S., Spano M., Fattorossi A., Mosiello L.F., D'Amelio R., Zichella L., and Doria G. Changes in thymocyte subsets induced by estradiol administration or pregnancy. Ann. N. Y. Acad. Sci. 650 (1992) 109-114
70. Yao G., Liang J., Han X., and Hou Y. In vivo modulation of the circulating lymphocyte subsets and monocytes by androgen. Int. Immunopharmacol. 3 (2003) 1853-1860
71. Leposavic G., Karapetrovic B., Micic M., and Kosec D. Prepubertal castration alters the phenotypic profile of adult rat thymocytes. Neuroimmunomodulation 2 (1995) 100-107
72. Olsen N.J., Watson M.B., Henderson G.S., and Kovacs W.J. Androgen deprivation induces phenotypic and functional changes in the thymus of adult male mice. Endocrinology 129 (1991) 2471-2476
73. Zoller A.L., and Kersh G.J. Estrogen induces thymic atrophy by eliminating early thymic progenitors and inhibiting proliferation of beta-selected thymocytes. J. Immunol. 176 (2006) 7371-7378
74. Kincade P.W., Medina K.L., Payne K.J., Rossi M.I.D., Tudor K.-S.R.S., Yamashita Y., and Kouro T. Early B-lymphocyte precursors and their regulation by sex steroids. Immunol. Rev. 175 (2000) 128-137
75. Medina K.L., Strasser A., and Kincade P.W. Estrogen influences the differentiation, proliferation, and survival of early B-lineage precursors. Blood 95 (2000) 2059-2067
76. Masuzawa T., Miyaura C., Onoe Y., Kusano K., Ohta H., Nozawa S., and Suda T. Estrogen deficiency stimulates B lymphopoiesis in mouse bone marrow. J. Clin. Invest. 94 (1994) 1090-1097
77. Biegel L.B., Flaws J.A., Hirshfield A.N., O'Connor J.C., Elliott G.S., Ladics G.S., Silbergeld E.K., Van Pelt C.S., Hurtt M.E., Cook J.C., and Frame S.R. 90-day feeding and one-generation reproduction study in Crl:CD BR rats with 17 beta-estradiol. Toxicol. Sci. 44 (1998) 116-142
78. Baba Y., Pelayo R., and Kincade P.W. Relationships between hematopoietic stem cells and lympocyte progenitors. Trends Immunol. 25 (2004) 645-649
79. Cohen J.H., Danel L., Cordier G., Saez S., and Revillard J.P. Sex steroid receptors in peripheral T cells: absence of androgen receptors and restriction of estrogen receptors to OKT8-positive cells. J. Immunol. 131 (1983) 2767-2771
80. Viselli S.M., Olsen N.J., Shults K., Steizer G., and Kovacs W.J. Immunochemical and flow cytometric analysis of androgen receptor expression in thymocytes. Mol. Cell. Endocrinol. 109 (1995) 19-26
81. Benten W.P., Lieberherr M., Giese G., Wrehlke C., Stamm O., Sekeris C.E., Mossmann H., and Wunderlich F. Functional testosterone receptors in plasma membranes of T cells. FASEB J. 13 (1999) 123-133
82. Samy T.S., Schwacha M.G., Cioffi W.G., Bland K.I., and Chaudry I.H. Androgen and estrogen receptors in splenic T lymphocytes: effects of flutamide and trauma-hemorrhage. Shock 14 (2000) 465-470
83. Olsen N.J., Gu X., and Kovacs W.J. Bone marrow stromal cells mediate androgenic suppression of B lymphocyte development. J. Clin. Invest. 108 (2001) 1697-1704
84. Benten W.P.M., Stephan C., and Wunderlich F. B cells express intracellular but not surface receptors for testosterone and estradiol. Steroids 67 (2002) 647-654
85. Erlandsson M.C., Ohlsson C., Gustafsson J.-A., and Carlston H. Role of oestrogen receptors alpha and beta in immune organ development and in oestrogen-mediated effects on thymus. Immunology 103 (2001) 17-25
86. Shim G.J., Wang L., Andersson S., Nagy N., Kis L.L., Zhang Q., Makela S., Warner M., and Gustafsson J.A. Disruption of the estrogen receptor beta gene in mice causes myeloproliferative disease resembling chronic myeloid leukemia with lymphoid blast crisis. Proc. Natl. Acad. Sci. USA 100 (2003) 6694-6699
87. Gustafsson J.A. Steroids and the scientist. Mol. Endocrinol. 19 (2005) 1412-1417
88. Mor G., Sapi E., Abrahams V.M., Rutherford T., Song J., Hao X.Y., Muzaffar S., and Kohen F. Interaction of the estrogen receptors with the Fas ligand promoter in human monocytes. J. Immunol. 170 (2003) 114-122
89. Marmont A.M. New horizons in the treatment of autoimmune diseases: immunoablation and stem cell transplantation. Annu. Rev. Med. 51 (2000) 115-134
90. Whitacre C.C. Sex differences in autoimmune disease. Nat. Immunol. 2 (2001) 777-780
91. S. Vukusic, C. Confavreux, Pregnancy and multiple sclerosis: the children of PRIMS, in: Clinical Neurology and Neurosurgery Proceedings of the 3rd Dubrovnik International Conference on Multiple Sclerosis - Dubrovnik, Croatia, 19-21 May 2005, vol. 108, 2006, pp. 266-270.
92. Tengstrand B., Carlstrom K., Fellander-Tsai L., and Hafstrom I. Abnormal levels of serum dehydroepiandrosterone, estrone, and estradiol in men with rheumatoid arthritis: high correlation between serum estradiol and current degree of inflammation. J. Rheumatol. 30 (2003) 2338-2343
93. Castagnetta L.A., Carruba G., Granata O.M., Stefano R., Miele M., Schmidt M., Cutolo M., and Straub R.H. Increased estrogen formation and estrogen to androgen ratio in the synovial fluid of patients with rheumatoid arthritis. J. Rheumatol. 30 (2003) 2597-2605
94. Grossman C.J., Roselle G.A., and Mendenhall C.L. Sex steroid regulation of autoimmunity. J. Steroid Biochem. Mol. Biol. 40 (1991) 649-659
95. Weinstein Y., Ran S., and Segal S. Sex-associated differences in the regulation of immune responses controlled by the MHC of the mouse. J. Immunol. 132 (1984) 656-661
96. Muller D., Chen M., Vikingsson A., Hildeman D., and Pederson K. Oestrogen influences CD4+ T-lymphocyte activity in vivo and in vitro in beta 2-microglobulin-deficient mice. Immunology 86 (1995) 162-167
97. Ansar Ahmed S., Penhale W.J., and Talal N. Sex hormones, immune responses, and autoimmune diseases. Mechanisms of sex hormone action. Am. J. Pathol. 121 (1985) 531-551
98. Jacobson J.D., and Ansari M.A. Immunomodulatory actions of gonadal steroids may be mediated by gonadotropin-releasing hormone. Endocrinology 145 (2004) 330-336
99. Okuyama R., Abo T., Seki S., Ohteki T., Sugiura K., Kusumi A., and Kumagai K. Estrogen administration activates extrathymic T cell differentiation in the liver. J. Exp. Med. 175 (1992) 661-669
100. Godfrey V.L., Wilkinson J.E., and Russell L.B. X-linked lymphoreticular disease in the scurfy (sf) mutant mouse. Am. J. Pathol. 138 (1991) 1379-1387
101. Blair P.J., Bultman S.J., Haas J.C., Rouse B.T., Wilkinson J.E., and Godfrey V.L. CD4+CD8- T cells are the effector cells in disease pathogenesis in the scurfy (sf) mouse. J. Immunol. 153 (1994) 3764-3774
102. Brunkow M.E., Jeffery E.W., Hjerrild K.A., Paeper B., Clark L.B., Yasayko S.A., Wilkinson J.E., Galas D., Ziegler S.F., and Ramsdell F. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat. Genet. 27 (2001) 68-73
103. Wing K., Suri-Payer E., and Rudin A. CD4+CD25+-regulatory T cells from mouse to man. Scand. J. Immunol. 62 (2005) 1-15
104. Gregg R., Smith C.M., Clark F.J., Dunnion D., Khan N., Chakraverty R., Nayak L., and Moss P.A. The number of human peripheral blood CD4+ CD25high regulatory T cells increases with age. Clin. Exp. Immunol. 140 (2005) 540-546
105. Cozzo C., Larkin III J., and Caton A.J. Cutting edge: self-peptides drive the peripheral expansion of CD4+CD25+ regulatory T cells. J. Immunol. 171 (2003) 5678-5682
106. Walker L.S., Chodos A., Eggena M., Dooms H., and Abbas A.K. Antigen-dependent proliferation of CD4+ CD25+ regulatory T cells in vivo. J. Exp. Med. 198 (2003) 249-258
107. Hsieh C.S., Liang Y., Tyznik A.J., Self S.G., Liggitt D., and Rudensky A.Y. Recognition of the peripheral self by naturally arising CD25+ CD4+ T cell receptors. Immunity 21 (2004) 267-277
108. Kovaiou R.D., and Grubeck-Loebenstein B. Age-associated changes within CD4+ T cells. Immunol. Lett. 107 (2006) 8-14
109. Tanriverdi F., Silveira L.F., MacColl G.S., and Bouloux P.M. The hypothalamic-pituitary-gonadal axis: immune function and autoimmunity. J. Endocrinol. 176 (2003) 293-304
110. Aluvihare V.R., Kallikourdis M., and Betz A.G. Regulatory T cells mediate maternal tolerance to the fetus. Nat. Immunol. 5 (2004) 266-271
111. Polanczyk M.J., Carson B.D., Subramanian S., Afentoulis M., Vandenbark A.A., Ziegler S.F., and Offner H. Cutting edge: estrogen drives expansion of the CD4+CD25+ regulatory T cell compartment. J. Immunol. 173 (2004) 2227-2230
112. Polanczyk M.J., Hopke C., Huan J., Vandenbark A.A., and Offner H. Enhanced FoxP3 expression and Treg cell function in pregnant and estrogen-treated mice. J. Neuroimmunol. 170 (2005) 85-92
113. Prieto G.A., and Rosenstein Y. Oestradiol potentiates the suppressive function of human CD4 CD25 regulatory T cells by promoting their proliferation. Immunology 118 (2006) 58-65
114. Sacks G., Sargent I., and Redman C. An innate view of human pregnancy. Immunol. Today 20 (1999) 114-118
115. Zoller A.L., Schnell F.J., and Kersh G.J. Murine pregnancy leads to reduced proliferation of maternal thymocytes and decreased thymic emigration. Immunology 121 (2007) 207-215
116. Reichert R.A., Weissman I.L., and Butcher E.C. Dual immunofluorescence studies of cortisone-induced thymic involution: evidence for a major cortical component to cortisone-resistant thymocytes. J. Immunol. 136 (1986) 3529-3534
117. Screpanti I., Morrone S., Meco D., Santoni A., Gulino A., Paolini R., Crisanti A., Mathieson B.J., and Frati L. Steroid sensitivity of thymocyte subpopulations during intrathymic differentiation. Effects of 17 beta-estradiol and dexamethasone on subsets expressing T cell antigen receptor or IL-2 receptor. J. Immunol. 142 (1989) 3378-3383
118. Purton J.F., Monk J.A., Liddicoat D.R., Kyparissoudis K., Sakkal S., Richardson S.J., Godfrey D.I., and Cole T.J. Expression of the glucocorticoid receptor from the 1A promoter correlates with T lymphocyte sensitivity to glucocorticoid-induced cell death. J. Immunol. 173 (2004) 3816-3824
119. Rijhsinghani A.G., Bhatia S.K., Tygrett L.T., and Waldschmidt T.J. Effect of pregnancy on thymic T cell development. Am. J. Reprod. Immunol. 35 (1996) 523-528
120. Tibbetts T.A., DeMayo F., Rich S., Conneely O.M., and O'Malley B.W. Progesterone receptors in the thymus are required for thymic involution during pregnancy and for normal fertility. Proc. Natl. Acad. Sci. USA 96 (1999) 12021-12026
121. Chrousos G.P., Torpy D.J., and Gold P.W. Interactions between the hypothalamic-pituitary-adrenal axis and the female reproductive system: clinical implications. Ann. Intern. Med. 129 (1998) 229-240
122. Mastorakos G., and Ilias I. Maternal and fetal hypothalamic-pituitary-adrenal axes during pregnancy and postpartum. Ann. N. Y. Acad. Sci. 997 (2003) 136-149
123. Zubkova I., Mostowski H., and Zaitseva M. Up-regulation of IL-7, stromal-derived factor-1 alpha, thymus-expressed chemokine, and secondary lymphoid tissue chemokine gene expression in the stromal cells in response to thymocyte depletion: implication for thymus reconstitution. J. Immunol. 175 (2005) 2321-2330
124. Clarke A.G., Gil A.L., and Kendall M.D. The effects of pregnancy on the mouse thymic epithelium. Cell Tissue Res. 275 (1994) 309-318
125. Kendall M.D., and Clarke A.G. The thymus in the mouse changes its activity during pregnancy: a study of the microenvironment. J. Anat. 197 Pt 3 (2000) 393-411
126. Phuc L.H., Papiernik M., Berrih S., and Duval D. Thymic involution in pregnant mice. I. Characterization of the remaining thymocyte subpopulations. Clin. Exp. Immunol. 44 (1981) 247-252
127. Weigent D.A., and Blalock J.E. Associations between the neuroendocrine and immune systems. J. Leukoc. Biol. 58 (1995) 137-150
128. Bouman A., Heineman M.J., and Faas M.M. Sex hormones and the immune response in humans. Hum. Reprod. Update 11 (2005) 411-423
129. Moscovitz H.C., Schmitt S., Kokoris G.J., Leiderman I.Z., and Gibson M.J. Thymocyte maturity in male and female hypogonadal mice and the effect of preoptic area brain grafts. J. Reprod. Immunol. 13 (1988) 263-275
130. Smithson G., Beamer W.G., Shultz K.L., Christianson S.W., Shultz L.D., and Kincade P.W. Increased B lymphopoiesis in genetically sex steroid-deficient hypogonadal (hpg) mice. J. Exp. Med. 180 (1994) 717-720
131. Min H., Montecino-rodriguez E., and Dorshkind K. Reassessing the role of growth hormone and sex steroids in thymic involution. Clin. Immunol. 118 (2006) 117-123
132. Stephan R.P., Reilly C.R., and Witte P.L. Impaired ability of bone marrow stromal cells to support B-lymphopoiesis with age. Blood 91 (1998) 75-88
133. Stephan R.P., Lill-Elghanian D.A., and Witte P.L. Development of B cells in aged mice: decline in the ability of pro-B cells to respond to IL-7 but not to other growth factors. J. Immunol. 158 (1997) 1598-1609
134. Miller J.P., and Allman D. The decline in B lymphopoiesis in aged mice reflects loss of very early B-lineage precursors. J. Immunol. 171 (2003) 2326-2330
135. Min H., Montecino-rodriguez E., and Dorshkind K. Effects of aging on the common lymphoid progenitor to Pro-B cell transition. J. Immunol. 176 (2006) 1007-1012
136. Xing Z., Ryan M.A., Daria D., Nattamai K.J., Van Zant G., Wang L., Zheng Y., and Geiger H. Increased hematopoietic stem cell mobilization in aged mice. Blood 108 (2006) 2190-2197
137. Rossi D.J., Bryder D., Zahn J.M., Ahlenius H., Sonu R., Wagers A.J., and Weissman I.L. Cell intrinsic alterations underlie hematopoietic stem cell aging. Proc. Natl. Acad. Sci. USA 102 (2005) 9194-9199
138. Kamminga L.M., van Os R., Ausema A., Noach E.J.K., Weersing E., Dontje B., Vellenga E., and De Haan G. Impaired hematopoietic stem cell functioning after serial transplantation and during normal aging. Stem Cells 23 (2005) 82-92
139. Rossi D.J., Bryder D., Seita J., Nussenzweig A., Hoeijmakers J., and Weissman I.L. Deficiencies in DNA damage repair limit the function of haematopoietic stem cells with age. Nature 447 (2007) 725-729
140. Bagnara G.P., Bonsi L., Strippoli P., Bonifazi F., Tonelli R., D'Addato S., Paganelli R., Scala E., Fagiolo U., Monti D., Cossarizza A., Bonafe M., and Franceschi C. Hemopoiesis in healthy old people and centenarians: well-maintained responsiveness of CD34+ cells to hemopoietic growth factors and remodeling of cytokine network. J. Gerontol. A Biol. Sci. Med. Sci. 55 (2000) B61-B66 discussion B67-B70
141. Anderlini P., Przepiorka D., Seong C., Smith T.L., Huh Y.O., Lauppe J., Champlin R., and Korbling M. Factors affecting mobilization of CD34+ cells in normal donors treated with filgrastim. Transfusion 37 (1997) 507-512
142. Offner F., Kerre T., De Smedt M., and Plum J. Bone marrow CD34 cells generate fewer T cells in vitro with increasing age and following chemotherapy. Br. J. Haematol. 104 (1999) 801-808
143. Lansdorp P.M., Dragowska W., Thomas T.E., Little M.T., and Mayani H. Age-related decline in proliferative potential of purified stem cell candidates. Blood Cells 20 (1994) 376-380 discussion 380-381
144. Vaziri H., Dragowska W., Allsopp R.C., Thomas T.E., Harley C.B., and Lansdorp P.M. Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. Proc. Natl. Acad. Sci. USA 91 (1994) 9857-9860
145. Ortman C.L., Dittmar K.A., Witte P.L., and Le P.T. Molecular characterisation of the mouse involuted thymus: aberrations in expression of transcription regulators in thymocyte and epithelial compartments. Int. Immunol. 14 (2002) 813-822
146. Sempowski G.D., Hale L.P., Sundy J.S., Massey J.M., Koup R.A., Douek D.C., Patel D.D., and Haynes B.F. Leukemia inhibitory factor, oncostatin M, IL-6, and stem cell factor mRNA expression in human thymus increases with age and is associated with thymic atrophy. J. Immunol. 164 (2000) 2180-2187
147. Andrew D., and Aspinall R. Age-associated thymic atrophy is linked to a decline in IL-7 production. Exp. Gerontol. 37 (2002) 455-463
148. Hollander G., Gill J., Zuklys S., Iwanami N., Liu C., and Takahama Y. Cellular and molecular events during early thymus development. Immunol. Rev. 209 (2006) 28-46
149. Forsey R.J., Thompson J.M., Ernerudh J., Hurst T.L., Strindhall J., Johansson B., Nilsson B.O., and Wikby A. Plasma cytokine profiles in elderly humans. Mech. Ageing Dev. 124 (2003) 487-493
150. Aggarwal S., Gollapudi S., and Gupta S. Increased TNF-alpha-induced apoptosis in lymphocytes from aged humans: changes in TNF-alpha receptor expression and activation of caspases. J. Immunol. 162 (1999) 2154-2161
151. Phelouzat M.A., Laforge T., Arbogast A., Quadri R.A., Boutet S., and Proust J.J. Susceptibility to apoptosis of T lymphocytes from elderly humans is associated with increased in vivo expression of functional Fas receptors. Mech. Ageing Dev. 96 (1997) 35-46
152. Potestio M., Caruso C., Gervasi F., Scialabba G., D'Anna C., Di Lorenzo G., Balistreri C.R., Candore G., and Romano G.C. Apoptosis and ageing. Mech. Ageing Dev. 102 (1998) 221-237
153. Eidinger D., and Garrett T.J. Studies of the regulatory effects of the sex hormones on antibody formation and stem cell differentiation. J. Exp. Med. 136 (1972) 1098-1116
154. Greenstein B.D., Fitzpatrick F.T., Adcock I.M., Kendall M.D., and Wheeler M.J. Reappearance of the thymus in old rats after orchidectomy: inhibition of regeneration by testosterone. J. Endocrinol. 110 (1986) 417-422
155. Kendall M.D., Fitzpatrick F.T., Greenstein B.D., Khoylou F., Safieh B., and Hamblin A. Reversal of ageing changes in the thymus of rats by chemical or surgical castration. Cell Tissue Res. 261 (1990) 555-564
156. Utsuyama M., Hirokawa K., Mancini C., Brunelli R., Leter G., and Doria G. Differential effects of gonadectomy on thymic stromal cells in promoting T cell differentiation in mice. Mech. Ageing Dev. 81 (1995) 107-117
157. Windmill K.F., and Lee V.W.K. Effects of castration on the lymphocytes of the thymus, spleen and lymph nodes. Tissue Cell 30 (1998) 104-111
158. Windmill K.F., Meade B.J., and Lee V.W. Effect of prepubertal gonadectomy and sex steroid treatment on the growth and lymphocyte populations of the rat thymus. Reprod. Fertil. Dev. 5 (1993) 73-81
159. Fitzpatrick F.T.A., Kendall M.D., Wheeler M.J., Adcock I.M., and Greenstein B.D. Reappearance of thymus of ageing rats after orchidectomy. J. Endocrinol. 106 (1985) R17-R19
160. Hamilton J.B., and Mestler G.E. Mortality and survival: comparison of eunuchs with intact men and women in a mentally retarded population. J. Gerontol. 24 (1969) 395-411
161. Pejcic-Karapetrovic B., Kosec D., and Leposavic G. Differential effects of male and female gonadal hormones on the intrathymic T cell maturation. Dev. Immunol. 8 (2001) 305-317
162. Goldberg G., Sutherland J.S., Hammett M., Milton M., Heng T.S., Chidgey A., and Boyd R. Sex steroid ablation enhances lymphoid recovery following autologous hematopoietic stem cell transplantation. Transplantation 80 (2005) 1604-1613
163. Sutherland J.S., Goldberg G.L., Hammett M.V., Uldrich A.P., Berzins S.P., Heng T.S., Blazar B.R., Millar J.L., Malin M.A., Chidgey A.P., and Boyd R.L. Activation of thymic regeneration in mice and humans following androgen blockade. J. Immunol. 175 (2005) 2741-2753
164. Olsen N.J., Viselli S.M., Shults K., Stelzer G., and Kovacs W.J. Induction of immature thymocyte proliferation after castration of normal male mice. Endocrinology 134 (1994) 107-113
165. Radojevic K., Arsenovic-Ranin N., Kosec D., Pesic V., Pilipovic I., Perisic M., Plecas-Solarovic B., and Leposavic G. Neonatal castration affects intrathymic kinetics of T-cell differentiation and the spleen T-cell level. J. Endocrinol. 192 (2007) 669-682
166. Roden A.J., Moser M.T., Tri S.D., Mercader M., Kuntz S.M., Dong H., Hurwitz A.A., McKean D.J., Celis E., Leibovich B.C., Allison J.P., and Kwon E.D. Augmentation of T cell levels and responses induced by androgen deprivation. J. Immunol. 173 (2004) 6098-6108
167. Page S.T., Plymate S.R., Bremner W.J., Matsumoto A.M., Hess D.L., Lin D.W., Amory J.K., Nelson P.S., and Wu J.D. Effect of medical castration on CD4+CD25+ T cells, CD8+ T cell IFN-{gamma} expression, and NK cells: a physiological role for testosterone and/or its metabolites 10.1152/ajpendo.00484.2005. Am. J. Physiol. Endocrinol. Metab. 290 (2006) E856-E863
168. Garcia-Perez M.A., Del Val R., Noguera I., Hermenegildo C., Pineda B., Martinez-Romero A., and Cano A. Estrogen receptor agonists and immune system in ovariectomized mice. Int. J. Immunopathol. Pharmacol. 19 (2006) 807-819
169. Utsuyama M., and Hirokawa K. Hypertrophy of the thymus and restoration of immune functions in mice and rats by gonadectomy. Mech. Ageing Dev. 47 (1989) 175-185
170. Deitch E.A., Ananthakrishnan P., Cohen D.B., Xu da Z., Feketeova E., and Hauser C.J. Neutrophil activation is modulated by sex hormones after trauma-hemorrhagic shock and burn injuries. Am. J. Physiol. Heart Circ. Physiol. 291 (2006) H1456-H1465
171. Zhao H., Tian Z., Hao J., and Chen B. Extragonadal aromatization increases with time after ovariectomy in rats. Reprod. Biol. Endocrinol. 3 (2005) 6
172. Forsberg J.G. Neonatal estrogen treatment and its consequences for thymus development, serum level of autoantibodies to cardiolipin, and the delayed-type hypersensitivity response. J. Toxicol. Environ. Health A 60 (2000) 185-213
173. Linde R., Doelle G.C., Alexander N., Kirchner F., Vale W., Rivier J., and Rabin D. Reversible inhibition of testicular steroidogenesis and spermatogenesis by a potent gonadotropin-releasing hormone agonist in normal men: an approach toward the development of a male contraceptive. N. Engl. J. Med. 305 (1981) 663-667
174. Conn P.M., and Crowley Jr. W.F. Gonadotropin-releasing hormone and its analogs. Annu. Rev. Med. 45 (1994) 391-405
175. Labrie F., Dupont A., Belanger A., Giguere M., Lacoursiere Y., Emond J., Monfette G., and Bergeron V. Combination therapy with flutamide and castration (LHRH agonist or orchiectomy) in advanced prostate cancer: a marked improvement in response and survival. J. Steroid Biochem. 23 (1985) 833-841
176. Weckermann D., and Harzmann R. Hormone therapy in prostate cancer: LHRH antagonists versus LHRH analogues. Eur. Urol. 46 (2004) 279-283 discussion 283-284
177. Taylor C.D., Elson P., and Trump D.L. Importance of continued testicular suppression in hormone-refractory prostate cancer. J. Clin. Oncol. 11 (1993) 2167-2172
178. Shaw M., Ray P., Rubenstein M., and Guinan P. Lymphocyte subsets in urologic cancer patients. Urol. Res. 15 (1987) 181-185
179. Mercader M., Bodner B.K., Moser M.T., Kwon P.S., Park E.S., Manecke R.G., Ellis T.M., Wojcik E.M., Yang D., Flanigan R.C., Waters W.B., Kast W.M., and Kwon E.D. T cell infiltration of the prostate induced by androgen withdrawal in patients with prostate cancer. Proc. Natl. Acad. Sci. USA 98 (2001) 14565-14570
180. Greenstein B.D., Fitzpatrick F.T.A., Kendall M.D., and Wheeler M.J. Regeneration of the thymus in old male rats treated with a stable analogue of LHRH. J. Endocrinol. 112 (1987) 345-350
181. Marchetti B., Guarcello V., Morale M.C., Bartoloni G., Raiti F., Palumbo Jr. G., Farinella Z., Cordaro S., and Scapagnini U. Luteinizing hormone-releasing hormone (LHRH) agonist restoration of age-associated decline of thymus weight, thymic LHRH receptors, and thymocyte proliferative capacity. Endocrinology 125 (1989) 1037-1045
182. Marchetti B., Morale M.C., Batticane N., Gallo F., Farinella Z., and Cioni M. Aging of the reproductive-neuroimmune axis. A crucial role for the hypothalamic neuropeptide luteinizing hormone-releasing hormone. Ann. N. Y. Acad. Sci. 621 (1991) 159-173
183. Huirne J.A., and Lambalk C.B. Gonadotropin-releasing-hormone-receptor antagonists. Lancet 358 (2001) 1793-1803
184. Zakharova L.A., Malyukova I.V., Adamskaya E.I., Kuznetsova T.A., and Shishkina I.V. Luteinizing hormone-releasing hormone in thymus and hypothalamus of rat fetuses: suppressing effect of antagonist and of antibodies on concanavalin A-induced proliferation of thymocytes. Biochemistry (Mosc) 65 (2000) 1135-1139
185. Matthews R.H., Emami M., Connaghan D.G., Holland H.K., and Morris L.E. Home administration of high-dose oral busulfan in patients undergoing hematopoietic stem cell transplantation. Bone Marrow Transpl. 39 (2007) 397-400
186. Ponzone R., Biglia N., Jacomuzzi M.E., Mariani L., Dominguez A., and Sismondi P. Antihormones in prevention and treatment of breast cancer. Ann. N. Y. Acad. Sci. 1089 (2006) 143-158
187. Sfikakis P.P., Kostomitsopoulos N., Kittas C., Stathopoulos J., Karayannacos P., Dellia-Sfikakis A., and Mitropoulos D. Tamoxifen exerts testosterone-dependent and independent effects on thymic involution. Int. J. Immunopharmacol. 20 (1998) 305-312
188. Bartke A., Mason M., Dalterio S., and Bex F. Effects of tamoxifen on plasma concentrations of testosterone and gonadotrophins in the male rat. J. Endocrinol. 79 (1978) 239-240
189. Azad N., LaPaglia N., Kirsteins L., Uddin S., Steiner J., Williams D.W., Lawrence A.M., and Emanuele N.V. Jurkat cell proliferative activity is increased by luteinizing hormone-releasing hormone. J. Endocrinol. 153 (1997) 241-249
190. Alpdogan O., Hubbard V.M., Smith O.M., Patel N., Lu S., Goldberg G.L., Gray D.H., Feinman J., Kochman A.A., Eng J.M., Suh D., Muriglan S.J., Boyd R.L., and van den Brink M.R. Keratinocyte growth factor (KGF) is required for postnatal thymic regeneration. Blood 107 (2006) 2453-2460
191. Fry T.J., and Mackall C.L. Current concepts of thymic aging. Springer Semin. Immunopathol. 24 (2002) 7-22
192. Mayr S., Walz C.R., Angele P., Hernandez-Richter T., Chaudry I.H., Loehe F., Jauch K.W., and Angele M.K. Castration prevents suppression of MHC class II (Ia) expression on macrophages after trauma-hemorrhage. J. Appl. Physiol. 101 (2006) 448-453
193. Messingham K.A., Shirazi M., Duffner L.A., Emanuele M.A., and Kovacs E.J. Testosterone receptor blockade restores cellular immunity in male mice after burn injury. J. Endocrinol. 169 (2001) 299-308
194. Imado T., Iwasaki T., Kataoka Y., Kuroiwa T., Hara H., Fujimoto J., and Sano H. Hepatocyte growth factor preserves graft-versus-leukemia effect and T-cell reconstitution after marrow transplantation. Blood 104 (2004) 1542-1549
195. Aspinall R., Pido-Lopez J., Imami N., Henson S.M., Ngom P.T., Morre M., Niphuis H., Remarque E., Rosenwirth B., and Heeney J.L. Old rhesus macaques treated with interleukin-7 show increased TREC levels and respond well to influenza vaccination. Rejuvenat. Res. 10 (2007) 5-17
196. Chu Y.W., Memon S.A., Sharrow S.O., Hakim F.T., Eckhaus M., Lucas P.J., and Gress R.E. Exogenous IL-7 increases recent thymic emigrants in peripheral lymphoid tissue without enhanced thymic function. Blood 104 (2004) 1110-1119
197. Alpdogan O., Schmaltz C., Muriglan S.J., Kappel B.J., Perales M.-A., Rotolo J.A., Halm J.A., Rich B.E., and Brink M.R.M.v.d. Administration of interleukin-7 after allogeneic bone marrow transplantation improves immune reconstitution without aggravating graft-versus-host disease. Blood 98 (2001) 2256-2265
198. Rossi S.W., Jeker L.T., Ueno T., Kuse S., Keller M.P., Zuklys S., Gudkov A.V., Takahama Y., Krenger W., Blazar B.R., and Hollander G.A. Keratinocyte growth factor (KGF) enhances postnatal T-cell development via enhancements in proliferation and function of thymic epithelial cells. Blood 109 (2007) 3803-3811
199. Seggewiss R., Lore K., Guenaga F.J., Pittaluga S., Mattapallil J., Chow C.K., Koup R.A., Camphausen K., Nason M.C., Meier-Schellersheim M., Donahue R.E., Blazar B.R., Dunbar C.E., and Douek D.C. Keratinocyte growth factor augments immune reconstitution after autologous hematopoietic progenitor cell transplantation in rhesus macaques. Blood 110 (2007) 441-449
200. Carlo-Stella C., Nicola M.D., Milani R., Longoni P., Milanesi M., Bifulco C., Stucchi C., Guidetti A., Cleris L., Formelli F., Garotta G., and Gianni A.M. Age- and irradiation-associated loss of bone marrow hematopoietic function in mice is reversed by recombinant human growth hormone. Exp. Hematol. 32 (2004) 171-178
201. Chen B.J., Cui X., Sempowski G.D., and Chao N.J. Growth hormone accelerates immune recovery following allogeneic T-cell-depleted bone marrow transplantation in mice. Exp. Hematol. 31 (2003) 953-958
202. Tian Z.-G., Woody M.A., Sun R., Welniak L.A., Raziuddin A., Funakoshi S., Tsarfaty G., Longo D.L., and Murphy W.J. Recombinant human growth hormone promotes hematopoietic reconstitution after syngeneic bone marrow transplantation in mice. Stem Cells 16 (1998) 193-199
203. Napolitano L.A., Lo J.C., Gotway M.B., mulligan K., Barbour J.D., Schmidt D., Grant R.M., Halvorsen R.A., Schambelan M., and McCune J.M. Increased thymic mass circulating naive CD4 T cells in HIV-1 infected adults treated with growth hormone. AIDS 16 (2002) 1103-1111
204. Carlo-Stella C., Di Nicola M., Milani R., Guidetti A., Magni M., Milanesi M., Longoni P., Matteucci P., Formelli F., Ravagnani F., Corradini P., and Gianni A.M. Use of recombinant human growth hormone (rhGH) plus recombinant human granulocyte colony-stimulating factor (rhG-CSF) for the mobilization and collection of CD34+ cells in poor mobilizers. Blood 103 (2004) 3287-3295
205. Sirohi B., Powles R., Morgan G., Treleaven J., Kulkarni S., Horton C., Saso R., Rolfe D., Cook G., Shaw C., and Wass J. Use of physiological doses of human growth hormone in haematological patients receiving intensive chemotherapy promotes haematopoietic recovery: a double-blind randomized, placebo-controlled study. Bone Marrow Transpl. 39 (2007) 115-120
206. Ryan M.R., Shepherd R., Leavey J.K., Gao Y., Grassi F., Schnell F.J., Qian W.P., Kersh G.J., Weitzmann M.N., and Pacifici R. An IL-7-dependent rebound in thymic T cell output contributes to the bone loss induced by estrogen deficiency. Proc. Natl. Acad. Sci. USA 102 (2005) 16735-16740